Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Schlaak

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
International Journal of STD & AIDS|September 21, 2000
Rapid development of Epstein-Barr virus-associated Hodgkin's disease after cessation of foscarnet therapy in an HIV-infected patientC Schramm, J F Schlaak, P R Galle
British Journal of Pharmacology|October 18, 2012
IFN-α subtypes: distinct biological activities in anti-viral therapyK Gibbert, J F Schlaak, D Yang, et al.
European Journal of Clinical Investigation|February 13, 2001
Oral supplementation with whey proteins increases plasma glutathione levels of HIV-infected patientsP Micke, K M Beeh, J F Schlaak, et al.
Scandinavian Journal of Immunology|May 1, 1995
Anti-GD3 antibodies are potent activators of human gamma/delta and alpha/beta positive T cellsJ F Schlaak, C Claus, K H Meyer zum Büschenfelde, et al.
Medical Microbiology and Immunology|July 1, 1994
Human T helper cells reactive with somatic bacterial antigens belong to the Th1 subsetJ F Schlaak, P Nieder, K H Meyer zum Büschenfelde, et al.
Clinical and Experimental Rheumatology|March 1, 1996
Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathiesJ F Schlaak, I Pfers, K H Meyer Zum Büschenfelde, et al.
Journal of AIDS & Clinical Research|March 4, 2017
Microarrays-Enabled Hypothesis Generation: The Suspect Role of FNBP-1 in Neuropsychiatric Pathogenesis Associated with HIV and/or HCV InfectionA Katsounas, K R Wilting, R A Lempicki, et al.
Journal of Hepatology|February 12, 1998
Chronic hepatitis C: the viral load per liver cell before treatment as a new marker to predict long-term response to IFN-alpha therapyJ F Schlaak, M Trippler, I Ernst, et al.
Journal of Immunological Methods|January 12, 1994
A sensitive and specific bioassay for the detection of human interleukin-10J F Schlaak, E Schmitt, C Hüls, et al.
Clinical and Experimental Immunology|October 1, 1993
Analysis of the in vitro cytokine production by liver-infiltrating T cells of patients with autoimmune hepatitisJ F Schlaak, H Löhr, H Gallati, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
International Journal of STD & AIDS|September 21, 2000
Rapid development of Epstein-Barr virus-associated Hodgkin's disease after cessation of foscarnet therapy in an HIV-infected patientC Schramm, J F Schlaak, P R Galle
British Journal of Pharmacology|October 18, 2012
IFN-α subtypes: distinct biological activities in anti-viral therapyK Gibbert, J F Schlaak, D Yang, et al.
European Journal of Clinical Investigation|February 13, 2001
Oral supplementation with whey proteins increases plasma glutathione levels of HIV-infected patientsP Micke, K M Beeh, J F Schlaak, et al.
Scandinavian Journal of Immunology|May 1, 1995
Anti-GD3 antibodies are potent activators of human gamma/delta and alpha/beta positive T cellsJ F Schlaak, C Claus, K H Meyer zum Büschenfelde, et al.
Medical Microbiology and Immunology|July 1, 1994
Human T helper cells reactive with somatic bacterial antigens belong to the Th1 subsetJ F Schlaak, P Nieder, K H Meyer zum Büschenfelde, et al.
Clinical and Experimental Rheumatology|March 1, 1996
Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathiesJ F Schlaak, I Pfers, K H Meyer Zum Büschenfelde, et al.
Journal of AIDS & Clinical Research|March 4, 2017
Microarrays-Enabled Hypothesis Generation: The Suspect Role of FNBP-1 in Neuropsychiatric Pathogenesis Associated with HIV and/or HCV InfectionA Katsounas, K R Wilting, R A Lempicki, et al.
Journal of Hepatology|February 12, 1998
Chronic hepatitis C: the viral load per liver cell before treatment as a new marker to predict long-term response to IFN-alpha therapyJ F Schlaak, M Trippler, I Ernst, et al.
Journal of Immunological Methods|January 12, 1994
A sensitive and specific bioassay for the detection of human interleukin-10J F Schlaak, E Schmitt, C Hüls, et al.
Clinical and Experimental Immunology|October 1, 1993
Analysis of the in vitro cytokine production by liver-infiltrating T cells of patients with autoimmune hepatitisJ F Schlaak, H Löhr, H Gallati, et al.
Pageof 5